Epoxyeicosatrienoic Acid Agonist Regulates Human Mesenchymal Stem Cell–Derived Adipocytes Through Activation ofHO-1-pAKTSignaling and a Decrease inPPARγ
- 1 December 2010
- journal article
- research article
- Published by Mary Ann Liebert Inc in Stem Cells and Development
- Vol. 19 (12), 1863-1873
- https://doi.org/10.1089/scd.2010.0098
Abstract
Human mesenchymal stem cells (MSCs) expressed substantial levels of CYP2J2, a major CYP450 involved in epoxyeicosatrienoic acid (EET) formation. MSCs synthesized significant levels of EETs (65.8 ± 5.8 pg/mg protein) and dihydroxyeicosatrienoic acids (DHETs) (15.83 ± 1.62 pg/mg protein), suggesting the presence of soluble epoxide hydrolase (sEH). The addition of an sEH inhibitor to MSC culture decreased adipogenesis. EETs decreased MSC-derived adipocytes in a concentration-dependent manner, 8,9- and 14,15-EET having the maximum reductive effect on adipogenesis. We examined the effect of 12-(3-hexylureido)dodec-8(Z)-enoic acid, an EET agonist, on MSC-derived adipocytes and demonstrated an increased number of healthy small adipocytes, attenuated fatty acid synthase (FAS) levels (P < 0.01), and reduced PPARγ, C/EBPα, FAS, and lipid accumulation (P < 0.05). These effects were accompanied by increased levels of heme oxygenase (HO)-1 and adiponectin (P < 0.05), and increased glucose uptake (P < 0.05). Inhibition of HO activity or AKT by tin mesoporphyrin (SnMP) and LY2940002, respectively, reversed EET-induced inhibition of adipogenesis, suggesting that activation of the HO-1-adiponectin axis underlies EET effect in MSCs. These findings indicate that EETs decrease MSC-derived adipocyte stem cell differentiation by upregulation of HO-1-adiponectin-AKT signaling and play essential roles in the regulation of adipocyte differentiation by inhibiting PPARγ, C/EBPα, and FAS and in stem cell development. These novel observations highlight the seminal role of arachidonic acid metabolism in MSCs and suggest that an EET agonist may have potential therapeutic use in the treatment of dyslipidemia, diabetes, and the metabolic syndrome.Keywords
This publication has 55 references indexed in Scilit:
- AMP-activated protein kinase: a stress-responsive kinase with implications for cardiovascular diseaseCurrent Opinion in Pharmacology, 2010
- HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineageBone, 2010
- Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiationJournal of Bone and Mineral Metabolism, 2009
- Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive ratsClinical Science, 2009
- Epoxyeicosatrienoic Acid Agonist Rescues the Metabolic Syndrome Phenotype of HO-2-Null MiceJournal of Pharmacology and Experimental Therapeutics, 2009
- Multiple signalling pathways redundantly control glucose transporter GLUT4 gene transcription in skeletal muscleThe Journal of Physiology, 2009
- 14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) Surrogates Containing Epoxide Bioisosteres: Influence upon Vascular Relaxation and Soluble Epoxide Hydrolase InhibitionJournal of Medicinal Chemistry, 2009
- Protective actions of epoxyeicosatrienoic acid: Dual targeting of cardiovascular PI3K and KATP channelsJournal of Molecular and Cellular Cardiology, 2009
- Improved cytochemical method for detecting Jordans' bodies in neutral lipid storage diseasesJournal of Clinical Pathology, 2006
- Reactive oxygen species have a causal role in multiple forms of insulin resistanceNature, 2006